CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence

[1]  A. Sapino,et al.  Cancer of Unknown Primary (CUP): genetic evidence for a novel nosological entity? A case report , 2020, EMBO Molecular Medicine.

[2]  Nuno A. Fonseca,et al.  A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns , 2020, Nature Communications.

[3]  W. Weichert,et al.  Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary , 2020, International journal of cancer.

[4]  Alexander V Penson,et al.  Development of Genome-Derived Tumor Type Prediction to Inform Clinical Cancer Care. , 2019, JAMA oncology.

[5]  Astrid Gall,et al.  Ensembl 2020 , 2019, Nucleic Acids Res..

[6]  N. Usman,et al.  Cancer of Unknown Primary: A Review on Clinical Guidelines in the Development and Targeted Management of Patients with the Unknown Primary Site , 2019, Cureus.

[7]  S. Ong,et al.  Molecular Basis of Tumor Heterogeneity in Endometrial Carcinosarcoma , 2019, Cancers.

[8]  Steven J. M. Jones,et al.  Application of a Neural Network Whole Transcriptome–Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers , 2019, JAMA network open.

[9]  N. Razavian,et al.  Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning , 2018, Nature Medicine.

[10]  Leland McInnes,et al.  UMAP: Uniform Manifold Approximation and Projection , 2018, J. Open Source Softw..

[11]  D. Feng,et al.  Cancer type prediction based on copy number aberration and chromatin 3D structure with convolutional neural networks , 2018, BMC Genomics.

[12]  Ashton C. Berger,et al.  A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers. , 2018, Cancer cell.

[13]  Chandra Sekhar Pedamallu,et al.  Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. , 2018, Cancer cell.

[14]  Paul T. Spellman,et al.  The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma , 2018, Cell reports.

[15]  Joshua M. Stuart,et al.  Resource Genomic , Pathway Networ k , and Immunologic Features Distinguishing Squamous Carcinomas Graphical , 2018 .

[16]  Leland McInnes,et al.  UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction , 2018, ArXiv.

[17]  N. Schultz,et al.  Clinical and molecular characterization of patients with cancer of unknown primary in the modern era , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  Manel Esteller,et al.  Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary , 2017, Nature Reviews Clinical Oncology.

[19]  Jun Yao,et al.  AKR1B1 promotes basal-like breast cancer progression by a positive feedback loop that activates the EMT program , 2017, The Journal of experimental medicine.

[20]  Rehan Akbani,et al.  Integrated Molecular Characterization of Uterine Carcinosarcoma. , 2017, Cancer cell.

[21]  Jian-Bing Fan,et al.  Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes , 2017, Clinical Cancer Research.

[22]  Benjamin J. Raphael,et al.  Integrated genomic characterization of oesophageal carcinoma , 2017, Nature.

[23]  Jinman Kim,et al.  DeepGene: an advanced cancer type classifier based on deep learning and somatic point mutations , 2016, BMC Bioinformatics.

[24]  R. Tothill,et al.  Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis. , 2016, The Lancet. Oncology.

[25]  A. Bass,et al.  Oesophageal adenocarcinoma and gastric cancer: should we mind the gap? , 2016, Nature Reviews Cancer.

[26]  Marcel J T Reinders,et al.  Pan-cancer subtyping in a 2D-map shows substructures that are driven by specific combinations of molecular characteristics , 2016, Scientific Reports.

[27]  Lior Pachter,et al.  Near-optimal probabilistic RNA-seq quantification , 2016, Nature Biotechnology.

[28]  M. Robinson,et al.  Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences , 2015, F1000Research.

[29]  D. Visscher,et al.  Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance). , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[30]  Steven J. M. Jones,et al.  Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma , 2016, Cell.

[31]  Steven J. M. Jones,et al.  Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. , 2016, The New England journal of medicine.

[32]  M. Robinson,et al.  Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. , 2015, F1000Research.

[33]  Charles M. Perou,et al.  Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy , 2015, BMC Medicine.

[34]  Jian Sun,et al.  Deep Residual Learning for Image Recognition , 2015, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[35]  A. Arance,et al.  Clinical implications of the intrinsic molecular subtypes of breast cancer. , 2015, Breast.

[36]  Steven J. M. Jones,et al.  The Molecular Taxonomy of Primary Prostate Cancer , 2015, Cell.

[37]  V. Deshpande,et al.  Difficult Diagnostic Problems in Pancreatobiliary Neoplasia. , 2015, Archives of pathology & laboratory medicine.

[38]  Steven J. M. Jones,et al.  Genomic Classification of Cutaneous Melanoma , 2015, Cell.

[39]  Kai Wang,et al.  Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Site: New Routes to Targeted Therapies. , 2015, JAMA oncology.

[40]  Raphael Gottardo,et al.  Orchestrating high-throughput genomic analysis with Bioconductor , 2015, Nature Methods.

[41]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.

[42]  R. Tothill,et al.  Development and validation of a gene expression tumour classifier for cancer of unknown primary , 2015, Pathology.

[43]  Jimmy Ba,et al.  Adam: A Method for Stochastic Optimization , 2014, ICLR.

[44]  N. Pavlidis,et al.  A mini review on cancer of unknown primary site: A clinical puzzle for the oncologists , 2014, Journal of advanced research.

[45]  Dumitru Erhan,et al.  Going deeper with convolutions , 2014, 2015 IEEE Conference on Computer Vision and Pattern Recognition (CVPR).

[46]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of gastric adenocarcinoma , 2014, Nature.

[47]  Steven J. M. Jones,et al.  Comprehensive molecular profiling of lung adenocarcinoma , 2014, Nature.

[48]  David M. Thomas,et al.  Massively‐parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary , 2013, The Journal of pathology.

[49]  Yuwei Zhang,et al.  Epidemiology of esophageal cancer. , 2013, World journal of gastroenterology.

[50]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[51]  A. Carvalho,et al.  Psychiatric manifestations, personality traits and health‐related quality of life in cancer of unknown primary site , 2013, Psycho-oncology.

[52]  M. Halks-Miller,et al.  A Multicenter Study Directly Comparing the Diagnostic Accuracy of Gene Expression Profiling and Immunohistochemistry for Primary Site Identification in Metastatic Tumors , 2013, The American journal of surgical pathology.

[53]  The Cancer Genome Atlas Research Network.  COMPREHENSIVE MOLECULAR CHARACTERIZATION OF CLEAR CELL RENAL CELL CARCINOMA , 2013, Nature.

[54]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.

[55]  J. Hainsworth,et al.  Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology. , 2013, Journal of the National Cancer Institute.

[56]  Steven J. M. Jones,et al.  Integrated genomic characterization of endometrial carcinoma , 2013, Nature.

[57]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[58]  M. Erlander,et al.  Blinded comparator study of immunohistochemical analysis versus a 92-gene cancer classifier in the diagnosis of the primary site in metastatic tumors. , 2013, The Journal of molecular diagnostics : JMD.

[59]  E. Oliva,et al.  Molecular events in endometrial carcinosarcomas and the role of high mobility group AT-hook 2 in endometrial carcinogenesis. , 2013, Human pathology.

[60]  Dirar Homouz,et al.  The 3D Organization of the Yeast Genome Correlates with Co-Expression and Reflects Functional Relations between Genes , 2013, PloS one.

[61]  J. Hainsworth,et al.  Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[62]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.

[63]  K. Oien,et al.  Diagnostic work-up of carcinoma of unknown primary: from immunohistochemistry to molecular profiling. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[64]  Günter P. Wagner,et al.  Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples , 2012, Theory in Biosciences.

[65]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.

[66]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[67]  Qinghua Xu,et al.  92-Gene Molecular Profiling in Identification of Cancer Origin: A Retrospective Study in Chinese Population and Performance within Different Subgroups , 2012, PloS one.

[68]  R. Aharonov,et al.  A Second-Generation MicroRNA-Based Assay for Diagnosing Tumor Tissue Origin , 2012 .

[69]  S. Dry,et al.  Multisite Validation Study to Determine Performance Characteristics of a 92-Gene Molecular Cancer Classifier , 2012, Clinical Cancer Research.

[70]  Benjamin E. Gross,et al.  The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. , 2012, Cancer discovery.

[71]  F. Markowetz,et al.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.

[72]  N. Pavlidis,et al.  Cancer of unknown primary site , 2012, The Lancet.

[73]  Christophe Massard,et al.  Carcinomas of an unknown primary origin—diagnosis and treatment , 2011, Nature Reviews Clinical Oncology.

[74]  R. Salunga,et al.  Performance and clinical evaluation of the 92-gene real-time PCR assay for tumor classification. , 2011, The Journal of molecular diagnostics : JMD.

[75]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.

[76]  R. Aharonov,et al.  Prospective Gene Signature Study Using microRNA to Identify the Tissue of Origin in Patients with Carcinoma of Unknown Primary , 2011, Clinical Cancer Research.

[77]  E. Oliva,et al.  Micro‐RNA signature of the epithelial–mesenchymal transition in endometrial carcinosarcoma , 2011, The Journal of pathology.

[78]  Yoshua Bengio,et al.  Understanding the difficulty of training deep feedforward neural networks , 2010, AISTATS.

[79]  A. Nobel,et al.  Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[80]  Robert Eckstein,et al.  Synoptic reporting improves histopathological assessment of pancreatic resection specimens , 2009, Pathology.

[81]  R. Tothill,et al.  Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome , 2008, Clinical Cancer Research.

[82]  G. Varadhachary.  Carcinoma of unknown primary origin. , 2007, Gastrointestinal cancer research : GCR.

[83]  R. Lenzi,et al.  Diagnostic strategies for unknown primary cancer , 2004, Cancer.

[84]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[85]  J. Hainsworth,et al.  Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset , 2013, International Journal of Clinical Oncology.

[86]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[87]  L. Buturovic,et al.  Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimens. , 2011, The Journal of molecular diagnostics : JMD.

[88]  J. Uhm.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2009 .

[89]  L. Breiman.  CONSISTENCY FOR A SIMPLE MODEL OF RANDOM FORESTS , 2004 .